Atlas Trials

Safety and Tolerability Study of Intravitreal VEGF-Trap Administration in Patients With Neovascular AMD

Clinical trial NCT00320775 · COMPLETED

Trial details

NCT number
NCT00320775
Sponsor
Regeneron Pharmaceuticals
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Macular Degeneration
Start date
2005-06-01
Primary completion
2008-06-01
Enrollment
51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.